 | • レポートコード：GIR-105X12858 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、開放隅角緑内障治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。開放隅角緑内障治療薬の種類別市場規模（プロスタグランジン、炭酸脱水酵素阻害剤、コリン作動薬、その他）、用途別市場規模（病院薬局、オンライン薬局、小売薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・開放隅角緑内障治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Merck、Allergan、Pfizer、Novartis、Bausch Health、Santen ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：プロスタグランジン、炭酸脱水酵素阻害剤、コリン作動薬、その他 ・用途別分析2016年-2026年：病院薬局、オンライン薬局、小売薬局 ・開放隅角緑内障治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・開放隅角緑内障治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・開放隅角緑内障治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・開放隅角緑内障治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・開放隅角緑内障治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Open Angle Glaucoma Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Open Angle Glaucoma Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Open Angle Glaucoma Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Open Angle Glaucoma Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Prostaglandins
Carbonic Anhydrase Inhibitor
Cholinergic Drugs
Others
Market segment by Application can be divided into
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
The key market players for global Open Angle Glaucoma Drugs market are listed below:
Merck
Allergan
Pfizer
Novartis
Bausch Health
Santen
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Open Angle Glaucoma Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Open Angle Glaucoma Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Prostaglandins
1.2.3 Carbonic Anhydrase Inhibitor
1.2.4 Cholinergic Drugs
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Open Angle Glaucoma Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Global Open Angle Glaucoma Drugs Market Size & Forecast
1.4.1 Global Open Angle Glaucoma Drugs Sales in Value (2016-2026))
1.4.2 Global Open Angle Glaucoma Drugs Sales in Volume (2016-2026)
1.4.3 Global Open Angle Glaucoma Drugs Price by Type (2016-2026) & (USD/Bottle)
1.5 Global Open Angle Glaucoma Drugs Production Capacity Analysis
1.5.1 Global Open Angle Glaucoma Drugs Total Production Capacity (2016-2026)
1.5.2 Global Open Angle Glaucoma Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Open Angle Glaucoma Drugs Market Drivers
1.6.2 Open Angle Glaucoma Drugs Market Restraints
1.6.3 Open Angle Glaucoma Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Open Angle Glaucoma Drugs Product and Services
2.1.4 Merck Open Angle Glaucoma Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Allergan
2.2.1 Allergan Details
2.2.2 Allergan Major Business
2.2.3 Allergan Open Angle Glaucoma Drugs Product and Services
2.2.4 Allergan Open Angle Glaucoma Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Open Angle Glaucoma Drugs Product and Services
2.3.4 Pfizer Open Angle Glaucoma Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Open Angle Glaucoma Drugs Product and Services
2.4.4 Novartis Open Angle Glaucoma Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Bausch Health
2.5.1 Bausch Health Details
2.5.2 Bausch Health Major Business
2.5.3 Bausch Health Open Angle Glaucoma Drugs Product and Services
2.5.4 Bausch Health Open Angle Glaucoma Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Santen
2.6.1 Santen Details
2.6.2 Santen Major Business
2.6.3 Santen Open Angle Glaucoma Drugs Product and Services
2.6.4 Santen Open Angle Glaucoma Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Open Angle Glaucoma Drugs Sales by Manufacturer
3.1 Global Open Angle Glaucoma Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Open Angle Glaucoma Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Open Angle Glaucoma Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Open Angle Glaucoma Drugs Manufacturer Market Share
3.4.2 Top 6 Open Angle Glaucoma Drugs Manufacturer Market Share
3.5 Global Open Angle Glaucoma Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Open Angle Glaucoma Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Open Angle Glaucoma Drugs Market Size by Region
4.1.1 Global Open Angle Glaucoma Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Open Angle Glaucoma Drugs Revenue by Region (2016-2026)
4.2 North America Open Angle Glaucoma Drugs Revenue (2016-2026)
4.3 Europe Open Angle Glaucoma Drugs Revenue (2016-2026)
4.4 Asia-Pacific Open Angle Glaucoma Drugs Revenue (2016-2026)
4.5 South America Open Angle Glaucoma Drugs Revenue (2016-2026)
4.6 Middle East and Africa Open Angle Glaucoma Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Open Angle Glaucoma Drugs Sales in Volume by Type (2016-2026)
5.2 Global Open Angle Glaucoma Drugs Revenue by Type (2016-2026)
5.3 Global Open Angle Glaucoma Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Open Angle Glaucoma Drugs Sales in Volume by Application (2016-2026)
6.2 Global Open Angle Glaucoma Drugs Revenue by Application (2016-2026)
6.3 Global Open Angle Glaucoma Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Open Angle Glaucoma Drugs Sales by Type (2016-2026)
7.2 North America Open Angle Glaucoma Drugs Sales by Application (2016-2026)
7.3 North America Open Angle Glaucoma Drugs Market Size by Country
7.3.1 North America Open Angle Glaucoma Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Open Angle Glaucoma Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Open Angle Glaucoma Drugs Sales by Type (2016-2026)
8.2 Europe Open Angle Glaucoma Drugs Sales by Application (2016-2026)
8.3 Europe Open Angle Glaucoma Drugs Market Size by Country
8.3.1 Europe Open Angle Glaucoma Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Open Angle Glaucoma Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Open Angle Glaucoma Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Open Angle Glaucoma Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Open Angle Glaucoma Drugs Market Size by Region
9.3.1 Asia-Pacific Open Angle Glaucoma Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Open Angle Glaucoma Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Open Angle Glaucoma Drugs Sales by Type (2016-2026)
10.2 South America Open Angle Glaucoma Drugs Sales by Application (2016-2026)
10.3 South America Open Angle Glaucoma Drugs Market Size by Country
10.3.1 South America Open Angle Glaucoma Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Open Angle Glaucoma Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Open Angle Glaucoma Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Open Angle Glaucoma Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Open Angle Glaucoma Drugs Market Size by Country
11.3.1 Middle East & Africa Open Angle Glaucoma Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Open Angle Glaucoma Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Open Angle Glaucoma Drugs Typical Distributors
12.3 Open Angle Glaucoma Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Open Angle Glaucoma Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Open Angle Glaucoma Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Open Angle Glaucoma Drugs Product and Services
Table 6. Merck Open Angle Glaucoma Drugs Sales (K Bottles), Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Allergan Basic Information, Manufacturing Base and Competitors
Table 8. Allergan Major Business
Table 9. Allergan Open Angle Glaucoma Drugs Product and Services
Table 10. Allergan Open Angle Glaucoma Drugs Sales (K Bottles), Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Open Angle Glaucoma Drugs Product and Services
Table 14. Pfizer Open Angle Glaucoma Drugs Sales (K Bottles), Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Novartis Basic Information, Manufacturing Base and Competitors
Table 16. Novartis Major Business
Table 17. Novartis Open Angle Glaucoma Drugs Product and Services
Table 18. Novartis Open Angle Glaucoma Drugs Sales (K Bottles), Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 20. Bausch Health Major Business
Table 21. Bausch Health Open Angle Glaucoma Drugs Product and Services
Table 22. Bausch Health Open Angle Glaucoma Drugs Sales (K Bottles), Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Santen Basic Information, Manufacturing Base and Competitors
Table 24. Santen Major Business
Table 25. Santen Open Angle Glaucoma Drugs Product and Services
Table 26. Santen Open Angle Glaucoma Drugs Sales (K Bottles), Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Global Open Angle Glaucoma Drugs Sales by Manufacturer (2019-2021e) & (K Bottles)
Table 28. Global Open Angle Glaucoma Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 29. Market Position of Manufacturers in Open Angle Glaucoma Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 30. Global Open Angle Glaucoma Drugs Production Capacity by Company, (K Bottles): 2020 VS 2021
Table 31. Head Office and Open Angle Glaucoma Drugs Production Site of Key Manufacturer
Table 32. Global Open Angle Glaucoma Drugs Sales by Region (2016-2021e) & (K Bottles)
Table 33. Global Open Angle Glaucoma Drugs Sales by Region (2021-2026) & (K Bottles)
Table 34. Global Open Angle Glaucoma Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 35. Global Open Angle Glaucoma Drugs Revenue by Region (2021-2026) & (USD Million)
Table 36. Global Open Angle Glaucoma Drugs Sales by Type (2016-2021e) & (K Bottles)
Table 37. Global Open Angle Glaucoma Drugs Sales by Type (2021-2026) & (K Bottles)
Table 38. Global Open Angle Glaucoma Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 39. Global Open Angle Glaucoma Drugs Revenue by Type (2021-2026) & (USD Million)
Table 40. Global Open Angle Glaucoma Drugs Price by Type (2016-2021e) & (USD/Bottle)
Table 41. Global Open Angle Glaucoma Drugs Price by Type (2021-2026) & (USD/Bottle)
Table 42. Global Open Angle Glaucoma Drugs Sales by Application (2016-2021e) & (K Bottles)
Table 43. Global Open Angle Glaucoma Drugs Sales by Application (2021-2026) & (K Bottles)
Table 44. Global Open Angle Glaucoma Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 45. Global Open Angle Glaucoma Drugs Revenue by Application (2021-2026) & (USD Million)
Table 46. Global Open Angle Glaucoma Drugs Price by Application (2016-2021e) & (USD/Bottle)
Table 47. Global Open Angle Glaucoma Drugs Price by Application (2021-2026) & (USD/Bottle)
Table 48. North America Open Angle Glaucoma Drugs Sales by Country (2016-2021e) & (K Bottles)
Table 49. North America Open Angle Glaucoma Drugs Sales by Country (2021-2026) & (K Bottles)
Table 50. North America Open Angle Glaucoma Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 51. North America Open Angle Glaucoma Drugs Revenue by Country (2021-2026) & (USD Million)
Table 52. North America Open Angle Glaucoma Drugs Sales by Type (2016-2021e) & (K Bottles)
Table 53. North America Open Angle Glaucoma Drugs Sales by Type (2021-2026) & (K Bottles)
Table 54. North America Open Angle Glaucoma Drugs Sales by Application (2016-2021e) & (K Bottles)
Table 55. North America Open Angle Glaucoma Drugs Sales by Application (2021-2026) & (K Bottles)
Table 56. Europe Open Angle Glaucoma Drugs Sales by Country (2016-2021e) & (K Bottles)
Table 57. Europe Open Angle Glaucoma Drugs Sales by Country (2021-2026) & (K Bottles)
Table 58. Europe Open Angle Glaucoma Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 59. Europe Open Angle Glaucoma Drugs Revenue by Country (2021-2026) & (USD Million)
Table 60. Europe Open Angle Glaucoma Drugs Sales by Type (2016-2021e) & (K Bottles)
Table 61. Europe Open Angle Glaucoma Drugs Sales by Type (2021-2026) & (K Bottles)
Table 62. Europe Open Angle Glaucoma Drugs Sales by Application (2016-2021e) & (K Bottles)
Table 63. Europe Open Angle Glaucoma Drugs Sales by Application (2021-2026) & (K Bottles)
Table 64. Asia-Pacific Open Angle Glaucoma Drugs Sales by Region (2016-2021e) & (K Bottles)
Table 65. Asia-Pacific Open Angle Glaucoma Drugs Sales by Region (2021-2026) & (K Bottles)
Table 66. Asia-Pacific Open Angle Glaucoma Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 67. Asia-Pacific Open Angle Glaucoma Drugs Revenue by Region (2021-2026) & (USD Million)
Table 68. Asia-Pacific Open Angle Glaucoma Drugs Sales by Type (2016-2021e) & (K Bottles)
Table 69. Asia-Pacific Open Angle Glaucoma Drugs Sales by Type (2021-2026) & (K Bottles)
Table 70. Asia-Pacific Open Angle Glaucoma Drugs Sales by Application (2016-2021e) & (K Bottles)
Table 71. Asia-Pacific Open Angle Glaucoma Drugs Sales by Application (2021-2026) & (K Bottles)
Table 72. South America Open Angle Glaucoma Drugs Sales by Country (2016-2021e) & (K Bottles)
Table 73. South America Open Angle Glaucoma Drugs Sales by Country (2021-2026) & (K Bottles)
Table 74. South America Open Angle Glaucoma Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 75. South America Open Angle Glaucoma Drugs Revenue by Country (2021-2026) & (USD Million)
Table 76. South America Open Angle Glaucoma Drugs Sales by Type (2016-2021e) & (K Bottles)
Table 77. South America Open Angle Glaucoma Drugs Sales by Type (2021-2026) & (K Bottles)
Table 78. South America Open Angle Glaucoma Drugs Sales by Application (2016-2021e) & (K Bottles)
Table 79. South America Open Angle Glaucoma Drugs Sales by Application (2021-2026) & (K Bottles)
Table 80. Middle East & Africa Open Angle Glaucoma Drugs Sales by Country (2016-2021e) & (K Bottles)
Table 81. Middle East & Africa Open Angle Glaucoma Drugs Sales by Country (2021-2026) & (K Bottles)
Table 82. Middle East & Africa Open Angle Glaucoma Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 83. Middle East & Africa Open Angle Glaucoma Drugs Revenue by Country (2021-2026) & (USD Million)
Table 84. Middle East & Africa Open Angle Glaucoma Drugs Sales by Type (2016-2021e) & (K Bottles)
Table 85. Middle East & Africa Open Angle Glaucoma Drugs Sales by Type (2021-2026) & (K Bottles)
Table 86. Middle East & Africa Open Angle Glaucoma Drugs Sales by Application (2016-2021e) & (K Bottles)
Table 87. Middle East & Africa Open Angle Glaucoma Drugs Sales by Application (2021-2026) & (K Bottles)
Table 88. Direct Channel Pros & Cons
Table 89. Indirect Channel Pros & Cons
Table 90. Open Angle Glaucoma Drugs Typical Distributors
Table 91. Open Angle Glaucoma Drugs Typical Customers
List of Figures
Figure 1. Open Angle Glaucoma Drugs Picture
Figure 2. Global Open Angle Glaucoma Drugs Sales Market Share by Type in 2020
Figure 3. Prostaglandins
Figure 4. Carbonic Anhydrase Inhibitor
Figure 5. Cholinergic Drugs
Figure 6. Others
Figure 7. Global Open Angle Glaucoma Drugs Sales Market Share by Application in 2020
Figure 8. Hospital Pharmacies
Figure 9. Online Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Global Open Angle Glaucoma Drugs Market Size, (USD Million) & (K Bottles): 2020 VS 2021 VS 2026
Figure 12. Global Open Angle Glaucoma Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Open Angle Glaucoma Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Open Angle Glaucoma Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Open Angle Glaucoma Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Open Angle Glaucoma Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Open Angle Glaucoma Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Open Angle Glaucoma Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Open Angle Glaucoma Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Open Angle Glaucoma Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Open Angle Glaucoma Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Open Angle Glaucoma Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Open Angle Glaucoma Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Open Angle Glaucoma Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Open Angle Glaucoma Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Open Angle Glaucoma Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Open Angle Glaucoma Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Open Angle Glaucoma Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Open Angle Glaucoma Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Open Angle Glaucoma Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Open Angle Glaucoma Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Open Angle Glaucoma Drugs Sales (2016-2026) & (K Bottles)
Figure 33. Global Open Angle Glaucoma Drugs Production Capacity (2016-2026) & (K Bottles)
Figure 34. Global Open Angle Glaucoma Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Open Angle Glaucoma Drugs Market Drivers
Figure 36. Open Angle Glaucoma Drugs Market Restraints
Figure 37. Open Angle Glaucoma Drugs Market Trends
Figure 38. Global Open Angle Glaucoma Drugs Sales Market Share by Manufacturer in 2020
Figure 39. Global Open Angle Glaucoma Drugs Revenue Market Share by Manufacturer in 2020
Figure 40. Open Angle Glaucoma Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Open Angle Glaucoma Drugs Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Open Angle Glaucoma Drugs Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Open Angle Glaucoma Drugs Sales Market Share by Region (2016-2026)
Figure 44. Global Open Angle Glaucoma Drugs Revenue Market Share by Region (2016-2026)
Figure 45. North America Open Angle Glaucoma Drugs Revenue (2016-2026) & (USD Million)
Figure 46. Europe Open Angle Glaucoma Drugs Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Open Angle Glaucoma Drugs Revenue (2016-2026) & (USD Million)
Figure 48. South America Open Angle Glaucoma Drugs Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Open Angle Glaucoma Drugs Revenue (2016-2026) & (USD Million)
Figure 50. Global Open Angle Glaucoma Drugs Sales Market Share by Type (2016-2026)
Figure 51. Global Open Angle Glaucoma Drugs Revenue Market Share by Type (2016-2026)
Figure 52. Global Open Angle Glaucoma Drugs Price by Type (2016-2026) & (USD/Bottle)
Figure 53. Global Open Angle Glaucoma Drugs Sales Market Share by Application (2016-2026)
Figure 54. Global Open Angle Glaucoma Drugs Revenue Market Share by Application (2016-2026)
Figure 55. Global Open Angle Glaucoma Drugs Price by Application (2016-2026) & (USD/Bottle)
Figure 56. North America Open Angle Glaucoma Drugs Sales Market Share by Country (2016-2026)
Figure 57. North America Open Angle Glaucoma Drugs Revenue Market Share by Country (2016-2026)
Figure 58. North America Open Angle Glaucoma Drugs Sales Market Share by Type (2016-2026)
Figure 59. North America Open Angle Glaucoma Drugs Sales Market Share by Application (2016-2026)
Figure 60. Europe Open Angle Glaucoma Drugs Sales Market Share by Country (2016-2026)
Figure 61. Europe Open Angle Glaucoma Drugs Revenue Market Share by Country (2016-2026)
Figure 62. Europe Open Angle Glaucoma Drugs Sales Market Share by Type (2016-2026)
Figure 63. Europe Open Angle Glaucoma Drugs Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Open Angle Glaucoma Drugs Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Open Angle Glaucoma Drugs Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Open Angle Glaucoma Drugs Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Open Angle Glaucoma Drugs Sales Market Share by Application (2016-2026)
Figure 68. South America Open Angle Glaucoma Drugs Sales Market Share by Country (2016-2026)
Figure 69. South America Open Angle Glaucoma Drugs Revenue Market Share by Country (2016-2026)
Figure 70. South America Open Angle Glaucoma Drugs Sales Market Share by Type (2016-2026)
Figure 71. South America Open Angle Glaucoma Drugs Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Open Angle Glaucoma Drugs Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Open Angle Glaucoma Drugs Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Open Angle Glaucoma Drugs Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Open Angle Glaucoma Drugs Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
緑内障治療の世界市場2018-2025 Glaucoma is a disease characterized by fluid builds up in the front part of your eye which results in damages to the eye’s optic nerve which may lead to blindness if left untreated. Open angle glaucoma (OAG) is the most common type of glaucoma followed by closed angle glaucoma (CAG) and these two ac…- 緑内障治療薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Glaucoma is chronic, degenerative disorder that damages the eye's optic nerve, may result in vision loss and blindness. Factors such, high prevalence of glaucoma, technological advancement in diagnostic technique, rising treatment awareness are driving the market growth of glaucoma therapeutics glob…
- OTC外用薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Topical drugs are used for the application where body surfaces such as the skin or mucous membranes to treat ailments. OTC Topical drugs are epicutaneous medication that are applied in the skin directly. The large range of classes included in the topical drugs are creams, foams, gels, lotions and oi…
- 眼科用医薬品の世界市場2018-2025 Ophthalmic drugs are extensively used to treat glaucoma, cataract, diabetic retinopathy, and other ophthalmic disorders. Introduction of novel ocular drug delivery approaches in the market has driven the manufacturers to develop innovative therapeutic approaches for the treatment of ophthalmic disor…
- 世界の腫瘍壊死因子（TNF）阻害薬市場 2021：企業別、地域別、種類・用途別 The Tumor Necrosis Factor (TNF) Inhibitor Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…